FDA Center for Drug Evaluation & Research Issues Warning Letter to Suretec Innovations
August 19, 2026
August 19, 2026
WASHINGTON, Aug. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Suretec Innovations LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Travis Brady, President, Suretec Innovations, LLC, 7055 South Lindell Road, Las Vegas, NV 89118, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26-11 . . .
* * *
Recipient: Mr. Travis Brady, President, Suretec Innovations, LLC, 7055 South Lindell Road, Las Vegas, NV 89118, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26-11 . . .